Harrow Health Inc
NASDAQ:HROW

Watchlist Manager
Harrow Health Inc Logo
Harrow Health Inc
NASDAQ:HROW
Watchlist
Price: 31.37 USD -0.92% Market Closed
Market Cap: 1.2B USD

Wall Street
Price Targets

HROW Price Targets Summary
Harrow Health Inc

Wall Street analysts forecast HROW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HROW is 56.98 USD with a low forecast of 42.42 USD and a high forecast of 68.25 USD.

Lowest
Price Target
42.42 USD
35% Upside
Average
Price Target
56.98 USD
82% Upside
Highest
Price Target
68.25 USD
118% Upside
Harrow Health Inc Competitors:
Price Targets
LLY
Eli Lilly and Co
24% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
12% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
3% Downside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
5% Upside
TLRY
Tilray Brands Inc
125% Upside
512
Grand Pharmaceutical Group Ltd
5% Downside
4507
Shionogi & Co Ltd
9% Upside

Revenue
Forecast

Revenue Estimate
Harrow Health Inc

For the last 8 years the compound annual growth rate for Harrow Health Inc's revenue is 33%. The projected CAGR for the next 3 years is 40%.

33%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Harrow Health Inc

The compound annual growth rate of Harrow Health Inc's operating income for the next 3 years is 199%.

N/A
Past Growth
199%
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Net Income
Forecast

Net Income Estimate
Harrow Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HROW's stock price target?
Price Target
56.98 USD

According to Wall Street analysts, the average 1-year price target for HROW is 56.98 USD with a low forecast of 42.42 USD and a high forecast of 68.25 USD.

What is Harrow Health Inc's Revenue forecast?
Projected CAGR
40%

For the last 8 years the compound annual growth rate for Harrow Health Inc's revenue is 33%. The projected CAGR for the next 3 years is 40%.

What is Harrow Health Inc's Operating Income forecast?
Projected CAGR
199%

The compound annual growth rate of Harrow Health Inc's operating income for the next 3 years is 199%.

Back to Top